Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Atkins Diet Versus Levetiracetam for Refractory Epilepsy in Children
NCT04172311Phase 3Unknown
- Sponsor
- Lady Hardinge Medical College
- Start
- Nov 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levetiracetam in epilepsy (2 arms), sponsored by Lady Hardinge Medical College. Primary endpoint: Proportion of responders at 3 months. Status: unknown.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04172311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04172311.